Status:
UNKNOWN
Lycopene in Preventing Prostate Cancer in Healthy Participants
Lead Sponsor:
University of Illinois at Chicago
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
RATIONALE: Chemoprevention is the use of certain drugs or substances to keep cancer from forming, growing, or coming back. The use of lycopene, a substance found in tomatoes, may keep prostate cancer ...
Detailed Description
OBJECTIVES: Primary * Determine whether lycopene supplementation affects percent free and bound prostate-specific antigen (PSA) in healthy participants. Secondary * Determine whether lycopene redu...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Healthy participants
- No existing prostate disease
- PATIENT CHARACTERISTICS:
- Able to supply blood and urine samples
- Able to answer demographic and dietary recall questionnaires
- No hospital inpatients
- Not allergic to tomatoes or tomato products
- Not abusing alcohol or non-prescribed drugs
- No existing gastrointestinal disease or cancer
- PRIOR CONCURRENT THERAPY:
- At least 2 weeks since prior lycopene (in supplement form)
- No concurrent participation in another clinical trial
Exclusion
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00322114
Start Date
February 1 2006
Last Update
September 20 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Illinois Cancer Center
Chicago, Illinois, United States, 60612-7243